NO931246D0 - Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv) - Google Patents

Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv)

Info

Publication number
NO931246D0
NO931246D0 NO931246A NO931246A NO931246D0 NO 931246 D0 NO931246 D0 NO 931246D0 NO 931246 A NO931246 A NO 931246A NO 931246 A NO931246 A NO 931246A NO 931246 D0 NO931246 D0 NO 931246D0
Authority
NO
Norway
Prior art keywords
hepatites
hbv
virus
compositions
disease caused
Prior art date
Application number
NO931246A
Other languages
English (en)
Other versions
NO931246L (no
Inventor
Dennis W Adair
Kenneth A Smiles
Dannie King
Original Assignee
Oclassen Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oclassen Pharma Inc filed Critical Oclassen Pharma Inc
Publication of NO931246D0 publication Critical patent/NO931246D0/no
Publication of NO931246L publication Critical patent/NO931246L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO93931246A 1992-04-06 1993-03-31 Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv) NO931246L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86389092A 1992-04-06 1992-04-06
US95292792A 1992-09-25 1992-09-25
US07/959,004 US5432165A (en) 1992-04-06 1992-10-09 Methods for the treatment of infection caused by Hepatitis B virus (HBV)

Publications (2)

Publication Number Publication Date
NO931246D0 true NO931246D0 (no) 1993-03-31
NO931246L NO931246L (no) 1993-10-07

Family

ID=27420427

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931246A NO931246L (no) 1992-04-06 1993-03-31 Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv)

Country Status (26)

Country Link
US (1) US5432165A (no)
EP (1) EP0565412A1 (no)
JP (1) JPH069403A (no)
CN (1) CN1081879A (no)
AP (1) AP372A (no)
AU (1) AU662804B2 (no)
BE (1) BE1009181A5 (no)
BR (1) BR9306207A (no)
CA (1) CA2092356A1 (no)
EE (1) EE9400068A (no)
ES (1) ES2105923B1 (no)
FR (1) FR2689398B1 (no)
GR (1) GR930100111A (no)
IL (1) IL105169A0 (no)
IT (1) IT1264332B1 (no)
LV (1) LV10191B (no)
MD (1) MD940152A (no)
MX (1) MX9301922A (no)
NO (1) NO931246L (no)
NZ (1) NZ247188A (no)
OA (1) OA10102A (no)
PH (1) PH31116A (no)
PT (1) PT101238A (no)
SI (1) SI9300144A (no)
WO (1) WO1993019762A1 (no)
YU (1) YU23993A (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346627B1 (en) 1990-02-01 2002-02-12 Emory University Intermediates in the synthesis of 1,3-oxathiolane nucleoside enantiomers
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US6200952B1 (en) 1993-06-02 2001-03-13 Sciclone Pharmaceuticals, Inc. Combination therapy method for treating chronic hepatitis B
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
WO1996010649A1 (en) * 1994-09-30 1996-04-11 Southwest Foundation For Biomedical Research Isolated human hepatitis b virus polymerase and uses thereof
US6391859B1 (en) 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US5808040A (en) * 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
US6296882B1 (en) * 2000-06-12 2001-10-02 Manuel Viamonte, Jr. Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, and lemon oil
US8076303B2 (en) 2005-12-13 2011-12-13 Spring Bank Pharmaceuticals, Inc. Nucleotide and oligonucleotide prodrugs
EP2427213B1 (en) * 2009-05-08 2015-04-01 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as vaccine enhancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE147774C (no) *
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
US4594339A (en) * 1982-04-06 1986-06-10 Sloan-Kettering Institute For Cancer Research Anti-herpes virus compositions containing 5-substituted 1-2'(deoxy-2-'-substituted-β-d-arabinofuranosyl)pyrimedene nucleosides
US4666892A (en) * 1984-03-06 1987-05-19 Sloan-Kettering Memorial Cancer Center Method and composition for hepatitis treatment with pyrimidine nucleoside compounds

Also Published As

Publication number Publication date
ES2105923B1 (es) 1998-07-01
ES2105923A1 (es) 1997-10-16
AP372A (en) 1994-11-24
IL105169A0 (en) 1993-07-08
WO1993019762A1 (en) 1993-10-14
FR2689398A1 (fr) 1993-10-08
LV10191B (en) 1995-04-20
BR9306207A (pt) 1998-06-23
CA2092356A1 (en) 1993-10-07
US5432165A (en) 1995-07-11
IT1264332B1 (it) 1996-09-23
EE9400068A (et) 1995-12-15
PT101238A (pt) 1994-03-31
FR2689398B1 (fr) 1994-11-18
JPH069403A (ja) 1994-01-18
GR930100111A (el) 1993-12-30
MD940152A (ro) 1995-12-31
LV10191A (lv) 1994-10-20
EP0565412A1 (en) 1993-10-13
ITTO930226A1 (it) 1994-10-05
NO931246L (no) 1993-10-07
ITTO930226A0 (it) 1993-04-05
AP9300513A0 (en) 1993-04-30
NZ247188A (en) 1995-05-26
BE1009181A5 (fr) 1996-12-03
OA10102A (en) 1996-12-18
MX9301922A (es) 1993-10-01
CN1081879A (zh) 1994-02-16
SI9300144A (en) 1994-03-31
PH31116A (en) 1998-02-28
YU23993A (sh) 1997-05-28
AU3530293A (en) 1993-10-07
AU662804B2 (en) 1995-09-14

Similar Documents

Publication Publication Date Title
ITMI931522A0 (it) Composizione farmaceutiche per il trattamento dell'infezione da virus dell'epatite b (hbv)
DK156688A (da) Praeparat til behandling af virusinfektioner
CY2007034I1 (el) Εμβολιο εναντια στον ανθρωπινο ϊο θηλωματος (τυπος 18)
NO922949D0 (no) Forbindelser og fremgangsmaater for inhibering av hiv- og beslektede virus
DZ1706A1 (fr) Vaccin contre le virus de l'hepatite a.
NO931246D0 (no) Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv)
NO940810D0 (no) Behandling av virusinfeksjoner
EP0522081A4 (en) Inhibition of disease associated with immunodeficiency virus infection
FI941705A0 (fi) Menetelmä viruspatogeenien läpipääsyn estämiseksi
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
DK384387D0 (da) Erythromycin-derivater til forebyggelse og behandling af sygdomme fremkaldt af virus
PT88420A (pt) Process for the preparation of pharmaceutical compositions containing 1-(2'-deoxy-2'-fluoro-beta-d-arabinofuranosyl)-5-ethyluracil and a method for treating hepatitis virus infections by using said compositions
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
EP0452360A4 (en) Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
ZA932271B (en) Compositions for the treatment of infection and disease caused by hepatitis B virus (HBV)
NO933600D0 (no) Termostabile virus
IL106939A0 (en) Pharmaceutical compositions for treating viral infections
NO931340D0 (no) Forbindelser og fremgangsmaater for inhibering av hiv og beslektede virus
NO931339D0 (no) Forbindelser og fremgangsmaater for inhibering av hiv og beslektede virus
NO931337D0 (no) Forbindelser og fremgangsmaater for inhibering av hiv og beslektede virus
NO931338D0 (no) Forbindelser og fremgangsmaater for inhibering av hiv og beslektede virus
BR9205290A (pt) Vacine e metodo de tratamento de infeccao do virus de imunodeficiencia humana
FI971702A0 (fi) Hepatiitti-C-viruksen asialoglykoproteiinit
ZA902032B (en) Compositions and methods for treating viral infections
NO930550D0 (no) Metode og preparat for behandling av virale infeksjoner